Jazz Pharmaceuticals (JAZZ) Work In Process (2010 - 2019)

Jazz Pharmaceuticals' Work In Process history runs 10 years deep, the most recent figure standing at $31.3 million for Q1 2019.

• On a quarterly basis, Work In Process changed N/A year-over-year to $31.3 million in Q1 2019; TTM through Mar 2019 was $31.3 million, a N/A change from a year earlier, with the FY2018 full-year figure at $26.0 million, up 65.91% from the prior year.
• Work In Process climbed to $31.3 million in Q1 2019 per JAZZ's latest filing, from $26.0 million in the prior quarter.
• Across five years, Work In Process topped out at $31.3 million in Q1 2019 and bottomed at $11.8 million in Q4 2015.
• The 5-year median for Work In Process is $20.0 million (2017), against an average of $20.8 million.
• Across the five-year window, Work In Process fell 16.04% in 2017 and jumped 65.91% in 2018, its largest moves.
• Year by year, Work In Process stood at $11.8 million in 2015, then jumped by 57.9% to $18.7 million in 2016, then decreased by 16.04% to $15.7 million in 2017, then jumped by 65.91% to $26.0 million in 2018, then gained by 20.05% to $31.3 million in 2019.
• Per Business Quant, the three latest JAZZ Work In Process figures stand at $31.3 million (Q1 2019), $26.0 million (Q4 2018), and $24.0 million (Q2 2018).